• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


DaVitaRx Invests $8.75 Million To Expand Operations In Orlando, Florida Metro Area

DaVita Rx, LLC, a full-service pharmacy specializing in renal care, will invest $8.75 million to expand in Orange County, Florida, creating up to 100 jobs during the next two years.

“The Orlando metro area has been an excellent partner in our mission of improving pharmacy care for the chronically ill,” said DaVita Rx President, Josh Golomb. “With more than 20 million Americans struggling with kidney disease, our anticipated pharmacy expansion in Orlando will allow DaVita Rx to help more patients better manage their medications and improve their clinical outcomes.”

Governor Rick Scott said, “Creating jobs for Florida families is my top priority, and the announcement of 100 jobs for the Orange County area means more families will have the opportunity to live the American Dream. As we continue to support Florida’s growing economy and improving housing market, companies likes DaVita Rx will continue to find great opportunities in the Sunshine State. While Florida’s private sector has created more than 200,000 jobs in two years, we know our work isn’t done, and we’ll continue working hard to grow jobs and opportunities for Florida families.”

As an incentive Scott said the state, Orange County, Enterprise Florida and the Metro Orlando EDC collaborated in this project. DaVita Rx, LLC, was approved for a $300,000 Qualified Target Industry tax refund from the state and Orange County, which is paid after job goals and contract requirements are met.

“We look forward to DaVita Rx’s continued presence and success in the Orlando region, which adds to the region’s long term Life Science sector viability,” said Rick Weddle, President and CEO of the Metro Orlando EDC.


Exclusive Research